Filter announcements
Loading...
Raymed Labs Ltd is in the business of providing ophthalmological productsBusiness Overview: RMIL manufactures formulations with advanced technologies focusing into Preservative free Ophthalmic dosage for Conjunctivitis and Glaucoma Patient care. It also manufactures other formulations which are converted from suspension to solution. Company has a range of over 80 products....
Cresanto Global Limited has announced its unaudited financial results for the quarter ended June 30, 2025. These results, which underwent review by the Audit Committee and received approval from the Board of Directors, provide key insights into the company's recent financial performance. To ensure broad access, the company has published...
Cresanto Global's Board has approved a proposal for the reduction of share capital, subject to shareholder and NCLT approval. This move could restructure the company's equity base. The Board also approved significant related party transactions for the upcoming financial year. These involve entities like Cresanto India Private Limited (up to...
Cresanto Global's board has approved a **share capital reduction plan**, subject to shareholder and NCLT approval, aiming to streamline its capital structure. For compliance, M/s. Nidhi Bajaj & Associates were appointed as **Secretarial Auditor** for five years (FY25-26 to FY30-31) and Ms. Komal Bajaj as **Internal Auditor** for FY25-26. The...
Cresanto Global (formerly Raymed Labs) has filed its quarterly compliance report regarding share dematerialization. The company confirmed that all physical shares received from depository participants for conversion into electronic form during the quarter were processed accurately, with their status communicated to the depositories. Their Registrar and Share Transfer Agent further...
Cresanto Global Limited has announced a board meeting to review the financial results for the quarter and half-year. The company has published its standalone audited financial results for the fourth quarter and financial year ended March 31, 2025. These results have been made available in leading newspapers and on the...